Bridgette Collins-Burow
Associate Professor of Medicine, Hematology/Oncology · Tulane University School of Medicine
Credentials: · · · ·
History
- 2005–2008
- 2002–2005
Internal Medicine
- 1998–2002
- 1994–1998
Research
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
Breast Cancer Research · 2012 · Last of 7 authors · Corresponding · 210 citations
Cancer Research · 2011 · 135 citations
Nutrition and Cancer · 2000 · First of 4 authors · 112 citations
- MM
31 papers · 18 as a fellow
- BR
11 papers · 5 as a resident
8 papers · 1 as a resident
6 papers · 3 as a resident
- FL
6 papers
- GW
5 papers
5 papers
5 papers · 5 as a resident
Grants
- 2016–2022
Kinase Mediated Suppression of Metastasis in Breast Cancer
National Cancer Institute · R01
Contact PI · $1.8M · Tulane University of Louisiana
- 2004–2012
Mentoring a Cancer Genetics Program
National Center for Research Resources · P20
Project lead · $114.3K · Tulane University of Louisiana
Clinical trials
- 2009–2010
ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
Principal investigator · Withdrawn · Early phase 1
Tulane University Health Sciences Center